Free Trial

Fox Run Management L.L.C. Takes Position in Genpact Limited (NYSE:G)

Genpact logo with Business Services background
Remove Ads

Fox Run Management L.L.C. acquired a new stake in Genpact Limited (NYSE:G - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 15,573 shares of the business services provider's stock, valued at approximately $669,000.

Several other institutional investors have also added to or reduced their stakes in G. SRH Advisors LLC acquired a new stake in shares of Genpact in the 4th quarter valued at approximately $26,000. Manchester Capital Management LLC bought a new position in Genpact in the 4th quarter valued at approximately $38,000. Smartleaf Asset Management LLC boosted its position in Genpact by 416.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after buying an additional 783 shares in the last quarter. UMB Bank n.a. boosted its position in Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after buying an additional 433 shares in the last quarter. Finally, J.Safra Asset Management Corp grew its stake in shares of Genpact by 38.8% during the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock worth $69,000 after buying an additional 453 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the sale, the senior vice president now owns 151,182 shares of the company's stock, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is owned by company insiders.

Remove Ads

Analysts Set New Price Targets

A number of brokerages have recently commented on G. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and increased their price target for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Mizuho lifted their price target on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and upped their price objective for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Needham & Company LLC raised their price objective on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a report on Friday, February 7th. Six analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $48.44.

View Our Latest Stock Report on G

Genpact Trading Up 1.2 %

Shares of NYSE:G traded up $0.62 during trading on Tuesday, reaching $50.55. The stock had a trading volume of 1,420,107 shares, compared to its average volume of 1,296,331. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $56.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The firm's fifty day moving average is $50.38 and its 200 day moving average is $44.78. The stock has a market cap of $8.88 billion, a price-to-earnings ratio of 17.80, a P/E/G ratio of 1.84 and a beta of 1.16.

Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, equities analysts forecast that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.35%. This is a positive change from Genpact's previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact's payout ratio is presently 23.94%.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads